A novel, in-solution separation of endogenous cardiac sarcomeric proteins and identification of distinct charged variants of regulatory light chain.
The molecular conformation of the cardiac myosin motor is modulated by intermolecular interactions among the heavy chain, the light chains, myosin binding protein-C, and titin and is governed by post-translational modifications (PTMs). In-gel digestion followed by LC/MS/MS has classically been applied to identify cardiac sarcomeric PTMs; however, this approach is limited by protein size, pI, and difficulties in peptide extraction. We report a solution-based work flow for global separation of endogenous cardiac sarcomeric proteins with a focus on the regulatory light chain (RLC) in which specific sites of phosphorylation have been unclear. Subcellular fractionation followed by OFFGEL electrophoresis resulted in isolation of endogenous charge variants of sarcomeric proteins, including regulatory and essential light chains, myosin heavy chain, and myosin-binding protein-C of the thick filament. Further purification of RLC using reverse-phase HPLC separation and UV detection enriched for RLC PTMs at the intact protein level and provided a stoichiometric and quantitative assessment of endogenous RLC charge variants. Digestion and subsequent LC/MS/MS unequivocally identified that the endogenous charge variants of cardiac RLC focused in unique OFFGEL electrophoresis fractions were unphosphorylated (78.8%), singly phosphorylated (18.1%), and doubly phosphorylated (3.1%) RLC. The novel aspects of this study are that 1) milligram amounts of endogenous cardiac sarcomeric subproteome were focused with resolution comparable with two-dimensional electrophoresis, 2) separation and quantification of post-translationally modified variants were achieved at the intact protein level, 3) separation of intact high molecular weight thick filament proteins was achieved in solution, and 4) endogenous charge variants of RLC were separated; a novel doubly phosphorylated form was identified in mouse, and singly phosphorylated, singly deamidated, and deamidated/phosphorylated forms were identified and quantified in human non-failing and failing heart samples, thus demonstrating the clinical utility of the method.
Scruggs
Sarah B
SB
Department of Physiology and Biophysics, University of Illinois, Chicago, Illinois 60612, USA.
Reisdorph
Rick
R
Armstrong
Mike L
ML
Warren
Chad M
CM
Reisdorph
Nichole
N
Solaro
R John
RJ
Buttrick
Peter M
PM
D000328:Adult; D002851:Chromatography, High Pressure Liquid; D015180:Electrophoresis, Gel, Two-Dimensional; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009124:Muscle Proteins / Q000737:chemistry / Q000302:isolation & purification* / Q000378:metabolism; D009206:Myocardium / Q000737:chemistry*; D010766:Phosphorylation; D011487:Protein Conformation; D012518:Sarcomeres / Q000737:chemistry*; D013056:Spectrophotometry, Ultraviolet; D053719:Tandem Mass Spectrometry
D009124:Muscle Proteins
Mol Cell Biochem. 2003 Mar;245(1-2):77-89
12708747
J Exp Biol. 2007 Dec;210(Pt 24):4298-306
18055619
FEBS Lett. 1985 Sep 23;189(2):221-4
3840099
Mol Cell Proteomics. 2005 Oct;4(10):1419-40
16009968
Arch Biochem Biophys. 1998 Oct 15;358(2):313-9
9784245
Biochem J. 1992 Jul 1;285 ( Pt 1):311-7
1386218
IDrugs. 2009 Apr;12(4):243-51
19350469
J Biol Chem. 1991 Feb 15;266(5):2811-7
1671569
J Chromatogr. 1991 Dec 27;588(1-2):115-23
1818079
J Biol Chem. 1984 Dec 25;259(24):15587-96
6549009
Circ Res. 2008 Mar 14;102(5):571-80
18202317
Anal Chem. 1994 Aug 1;66(15):2529-36
8092487
Mol Cell Proteomics. 2006 Oct;5(10):1968-74
16849286
Acta Physiol Scand. 1999 Dec;167(4):327-9
10632635
J Chromatogr A. 2000 Oct 6;893(2):293-305
11073299
J Mol Cell Cardiol. 2003 Jul;35(7):833-40
12818574
Eur J Heart Fail. 2008 Sep;10(9):917-20
18678526
J Biol Chem. 2007 Apr 6;282(14):10360-9
17289664
Proc Natl Acad Sci U S A. 2001 Oct 23;98(22):12409-13
11606750
Heart Fail Rev. 2005 Sep;10(3):187-97
16416042
FASEB J. 2001 Nov;15(13):2415-22
11689466
Circ Res. 2002 Jun 14;90(11):1181-8
12065321
Electrophoresis. 2003 Jun;24(11):1695-702
12783444
Rapid Commun Mass Spectrom. 2001;15(4):291-6
11223961
Basic Res Cardiol. 1992;87 Suppl 1:129-41
1386730
Physiology (Bethesda). 2007 Apr;22:73-80
17420299
Biophys J. 1996 Aug;71(2):898-907
8842229
J Chromatogr A. 2005 Mar 4;1067(1-2):73-83
15844511
J Biol Chem. 2001 Mar 9;276(10):7086-92
11102452
Mol Cell Proteomics. 2004 Jun;3(6):577-85
14985449
Circ Res. 1998 Sep 7;83(5):471-80
9734469
Cell Biol Int Rep. 1988 Dec;12(12):1089-98
3224377
Am J Physiol Heart Circ Physiol. 2008 Aug;295(2):H647-56
18552161
Eur J Biochem. 1985 Oct 15;152(2):361-71
2414102
Cardiovasc Res. 2003 Feb;57(2):505-14
12566123
Proteomics. 2002 Jan;2(1):22-31
11788988
Am J Physiol. 1986 Apr;250(4 Pt 1):C657-60
3754389
Circulation. 2001 Sep 4;104(10):1140-6
11535570
Am J Physiol Heart Circ Physiol. 2004 Dec;287(6):H2712-8
15331360
Anal Biochem. 1989 Aug 1;180(2):205-10
2817350
Biochim Biophys Acta. 1971 Aug 6;245(1):259-62
4332100
Proteomics. 2006 Jul;6(14):4176-86
16791825
Biochemistry. 2004 Nov 30;43(47):15058-65
15554713
Anal Biochem. 1998 May 1;258(2):349-61
9570851
Mol Cell Biochem. 1995 Apr 12;145(1):89-96
7659082
Proteomics. 2004 Jul;4(7):1985-8
15221759
Proteomics. 2002 Feb;2(2):151-6
11840561
Eur J Heart Fail. 2006 Nov;8(7):764-6
17049305
J Biol Chem. 2009 Feb 20;284(8):5097-106
19106098
FEBS Lett. 1999 Jun 25;453(3):254-9
10405155